Safety and Efficacy of Treatment With the Anti–IL-23 Monoclonal Antibody QX004N in Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Anti-IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis: A Randomized Clinical Trial
JAMA Dermatol 2024 Dec 11;[EPub Ahead of Print], X Li, B Li, D Yang, M Wang, Q Li, N Wang, M Fang, J Liu, H Zhang, M Wu, C Li, X Zhu, Y Ding, S LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.